Key Takeaways:
- NewLeaf Symbiotics adds Greg Thompson, CEO of Intrinsyx Bio, as an independent director to its Board.
- Thompson brings over 25 years of experience in agriculture, biologicals, and commercialization.
- NewLeaf recently introduced TS201, a groundbreaking bioinsecticide for corn rootworm larvae.
- Thompson’s appointment aligns with NewLeaf’s next phase of growth and market expansion.
New Leadership for a Growing Innovator
NewLeaf Symbiotics, a global leader in Pink Pigmented Facultative Methylotrophs (PPFMs), announced today that Greg Thompson, CEO of Intrinsyx Bio, has joined its Board of Directors as an independent director. Thompson, a seasoned executive with a strong background in commercialization and agricultural biologicals, will officially take up the role in September 2024.
Brent Smith, CEO and President of NewLeaf Symbiotics, expressed enthusiasm for the new addition to the Board. “Greg’s industry experience with both full-scale agriculture and biological startups makes him a perfect fit for our Board of Directors. We look forward to his guidance and the perspective he will bring as NewLeaf enters its next phase of rapid growth,” said Smith.
Greg Thompson’s Expertise
Thompson brings a wealth of experience to NewLeaf’s Board, having worked in the agriculture and industrial sectors for over 25 years. His career includes leadership roles at prominent companies such as Intrinsyx Bio, PureField Ingredients, White Energy, Verdesian Life Sciences, and Nufarm. Additionally, Thompson has served in advisory roles at Bain & Company and is a Senior Operating Partner at Inverness Graham.
Throughout his career, Thompson has been instrumental in mergers and acquisitions, co-leading transactions totaling over $1.3 billion. His experience in executive roles and driving commercialization strategies, especially in biologicals, is seen as a key asset to NewLeaf’s future growth. Thompson also holds Board positions at Custom Agronomics and My Yield, bringing an impressive breadth of industry expertise to his new role at NewLeaf.
Expanding NewLeaf’s Innovative Portfolio
NewLeaf Symbiotics continues to push boundaries in agricultural biological solutions, recently introducing TS201, a revolutionary bioinsecticide designed to repel corn rootworm larvae. This product is just one of the many innovations in NewLeaf’s growing portfolio, which spans from biostimulants and bioinsecticides to nutrient use efficiency and greenhouse gas emission reduction technologies.
Thompson’s role on the Board will likely play a crucial part in advancing the commercialization of these technologies and expanding their market reach. “With my deep roots in and passion for the biological space and experience driving startups to success, this board appointment is a natural fit,” Thompson remarked. “I’ve been impressed with NewLeaf’s philosophy of science-led, performance-driven, and data-backed biological solutions.”
NewLeaf Symbiotics Latest News
Launches TS201 Biocontrol Technology (2024/03/07)
Corn Rootworm (CRW) presents an escalating challenge for farmers as it becomes resistant to traditional control methods. To address this, NewLeaf Symbiotics has introduced TS201, a biocontrol solution that taps into natural plant defenses, offering an innovative approach to CRW management. CEO Brent Smith emphasizes the importance of providing farmers with this new, research-backed technology in time for planting season. Testing has shown that TS201-treated plants are significantly less attractive to CRW larvae, resulting in healthier crops and higher yields. To enhance its availability, NewLeaf has partnered with industry leaders like Meristem, Low Mu Tech, and AMVAC to distribute TS201 widely.
NewLeaf Symbiotics Secures $45M in Series D Funding (2023/12/20)
NewLeaf Symbiotics has successfully raised $45 million in a series D financing round led by Gullspång Re. The company has experienced significant growth in the past three years, particularly in its PPFM technology applications, with an increase in its product-applied footprint from around 800,000 acres in 2022 to 11 million acres by 2024. With the new funding, NewLeaf plans to accelerate its efforts in various agricultural technologies, including advancements in biostimulants, microbial inoculants, biocontrol solutions, nitrogen use efficiency, and methane mitigation. The company also plans to launch a new EPA-registered biopesticide and develop biostimulants for peanut and cotton crops. Peter Odemark, Managing Director of Re:food, will join NewLeaf’s Board of Directors.
1 Comment